Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5214_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
31 Мб
Скачать
168
5 Filler Procedures Based ontheFacial Area
higher viscoelasticity than monophasic llers were recommended. Recently, monophasic llers with high viscoelasticity and low water retention capacity have been widely used.
5.2.7.3 Injection Technique
Augmentation of Dorsum and Radix
There are two methods of treatment—using a needle or cannula.
Firstly, the cannula method starts by creating an entry point between the nose tip and the colu­mella. Then insert it advancing while feeling it touching the cartilage or bone in the deep layer. Proceed from the space between lower lateral cartilages -> upper lateral cartilages (perichon­drium) -> nasal bone (periosteum) -> to radix. The upper boundary of ller injection is the level of the upper eyelid crease, and ller is slowly injected from just below this level with a retro­grade linear technique (Fig.5.65).
A 21–23G 5cm cannula is suitable for injec­tion. If the cannula is too long, it is likely to bend while entering at the supraperiosteum level and penetrate into the subcutaneous layer, resulting in vascular accidents.
To prevent this, pinch with the opposite hand, grab and lift the thick tissue which covers the deep fat layer, and then advance the cannula in the supraperiosteal layer.
You can check the depth of the cannula tip by palpating it with the other hand to see if it is prop­erly positioned in the deep layer or visually check by lifting the cannula with the syringe-held hand. If the cannula has entered the supercial layer, retract the cannula, and then advance it correctly into the deep layer.
Since a hump exists when correcting a hooked nose, the cannula cannot enter into the radix from the tip of the nose in one maneuver. This is because the cannula enters the supraperiosteal layer ini­tially but penetrates into the subcutaneous layer while passing the hump. There are three recom­mended injection methods to solve this problem.
• Make a second entry point just below the
hump for the cannula, insert the cannula, and
inject the ller retrograde from the radix to the hump.
• Inject with the cannula from the nose tip to the hump, and inject with a needle from the hump to the radix.
• Inject with only a needle. A needle is used to inject approximately three to ve points on the midline of the nose from the radix to nose tip (same as the following needle injection method).
Secondly, inject at the supraperiosteum level
using a needle. In the same way as the cannula method described above, you can inject it with the retrograde technique after going straight from the nose tip to the radix. Or you can inject ller directly above the supraperiosteum or the peri­chondrium after inserting the needle vertically or obliquely and dividing the treatment area into three to ve points (Fig.5.66).
It is not recommended to use a needle with a
small diameter, such as an insulin syringe, but a needle about 25G/27G is recommended. Since the ller is injected under high pressure inside the needle with a small inner diameter, a change in the physical properties of the ller may occur, and the inherent viscoelasticity may not be main­tained. If a diameter of the needle is small, the viscous ller in the needle lumen may result in a false-negative aspiration test just before ller injection (see Sect. 6.2.5).
Augmentation of Nose Tip
Similar to the nasal dorsum procedure, llers can be injected using a cannula or needle. Place the injection tool between the lower lateral cartilages and inject deeply over the cartilage.
Unlike the dorsum, the tip has a thick dermis,
and there is no soft subcutaneous fat layer. The bromuscular layer and dermis are tightly con­nected, so if a large amount of ller is injected, skin necrosis is likely to occur due to extravascu­lar compression even if injected into a deep space. Therefore, it is recommended to inject a small amount of medium viscosity ller with a droplet technique.
5.2 Midface
169
a
c
d
b
Fig. 5.65 Injection method using a cannula for nose aug­mentation. (a) Cannula is inserted on the midline of the nose. (b) Depth of cannula is supraperichondrium and supraperiosteum. (c) Location of entry point and direction
of cannula insertion. (d) MRI of the nose (sagittal view). Filler (high signaling) was placed on the supraperiosteum level with kind permission of DAEHAN medbook
170
Fig. 5.66 Injection method using a needle for nose aug-
mentation. Serial puncture method is a good option for needle injection
Augmentation of Columella
The procedure can be performed with both a nee­dle and a cannula, but a cannula is recommended because the needle is likely to damage the colu­mellar artery in a narrow space.
Insert the cannula to the medial crus of the lower lateral cartilage and advance it to the ante­rior nasal spine. Then inject using the retrograde linear threading technique.
The towing technique is applied to reinforce the support of the columella, but the support does not last long. It may be a good option to combine with a cog lifting thread to reinforce the support after the ller procedure.
When a small amount of toxin is injected into the depressor septi nasi muscle, the nose tip is lifted by releasing the tension of the muscle. Synergistic effect can be obtained by combining toxin with ller for columella correction.
Precautions for Nose Filler
• Make sure the midline of the nose is preserved
during ller injection.
• The injection plane should be supraperios-
teum/supraperichondrium to reduce the risk of
vascular compression and intravascular
injection.
5 Filler Procedures Based ontheFacial Area
• Do not inject too much volume of ller for correction of the nasal tip.
– Adjust the amount appropriately for the
second touch-up procedure as well as the rst procedure. After a certain period of time, when the ller is dissolved and the patient visits for further treatment, the tissue become dense and mobility of blood vessels are lessened by collagen formation due to previous pro­cedures. Thus, even the same amount of injection increases the chance of vascular compression after repetitive procedures. Therefore, it is advisable to perform the procedure with even more caution for cor­rection of the nasal tip.
– In case of a past history of nose surgery,
check the rigidity of the dermis and subcu­taneous fat layer by palpation, and if deemed, do not recommend a ller proce­dure or inject only a minimal amount. Patients often hide their history of nose sur­gery, so careful clinical examination is needed.
– When simultaneously treating the nasola-
bial fold and the nasal tip, the possibility of compression of the lateral nasal artery is increased, so the procedure should be divided into two sessions with small amount of injections.
• Thorough communication with patient about the area to be corrected before the procedure can reduce postoperative dissatisfaction.
5.2.7.4 Side Eect
Skin Necrosis
The nose is a site where skin necrosis frequently occurs as a side effect after ller treatment. The nose has a smaller space in between the bone (cartilage) and skin than other areas. Also, the dermis is thicker, so there is even less space for safe ller injection.
Therefore, ller injection into the nose
increases the possibility of necrosis due to extra­vascular compression by the ller mass. In par-
5.2 Midface
171
ticular, necrosis is likely to occur in the nasal tip which has thick skin, so it is better to avoid over­injecting llers with too high lifting capacity. Injecting ller into the supraperiosteum level, which is the deepest layer during the procedure, helps to prevent skin necrosis.
If the skin appears to be blanched after ller injection, it should be assessed whether it is caused by vasoconstrictors included in the anes­thetics. When there is suspicion of skin discolor­ation due to blood vessel compression, it is advisable to dissolve the ller with hyaluronidase to perform decompression (see Sect 6.2.1 com­plication—skin necrosis).
Blindness
In the ller procedure for nose augmentation, blindness occurs when ller product inadver­tently is injected into the artery and moves retro­grade through the dorsal nasal artery to the ophthalmic artery and eventually blocking the retinal artery. To prevent this, it is important to avoid injection into the dorsal nasal artery during radix treatment. Lift the soft tissue using a pinch­ing maneuver with the opposite hand, and then place the injection tool in the supraperiosteum layer. In addition, when the ller is injected, the dorsal nasal artery can be compressed with the opposite hand to prevent the backow of the ller into the ophthalmic artery.
Hematoma
The radix has intercanthal veins in the subcutane­ous layer, which may cause side effects from intravascular injection. In order to prevent this, it is preferable to pinch using the thumb and index
nger of the opposite hand to sufciently lift the subcutaneous fat and blood vessels before inject­ing ller into the supraperiosteum layer.

5.2.8 Nasolabial Fold

Considerations for Three Types of Nasolabial Folds
The nasolabial fold refers to lines that appear as the Chinese character for number 8 (八). Nasolabial folds are generally seen bilaterally, starting from border of the ala nasi and bridge of the nose and extend inferiorly to the cheeks. Nasolabial folds can be divided into three types depending on the cause (Fig.5.67).
The rst cause is lack of soft tissue volume in the paranasal area lateral to the ala nasi. There are patients who have depression over the maxillary canine fossa, which is the structure that supports the paranasal area. In such patients, relative to the nasolabial fat located superior to the nasolabial fold, there is barely any supercial fat in the region inferior to the nasolabial fold. Insufcient volume of the deep fat and soft tissues of the deeper layers deepens this depression lateral to the ala nasi. The soft tissue bulge superior to the fold and the sunken area resemble stairs. Although it is not an actual wrinkle, a crease-like boundary is formed (Fig.5.68).
The second type is caused by difference in skin characteristics. Relative to the skin superior to the fold, the skin of the upper lip region adheres tightly to the underlying orbicularis oculi muscle. With the aging process, the skin superior to the
Fig. 5.67 Three types of the nasolabial folds
172
gion
Loose subcutaneous la on the cheek r
er
Fig. 5.68 Volume deciency of the canine fossa
5 Filler Procedures Based ontheFacial Area
Tr iangular depression of the paranasal re
Fig. 5.69 Tightness difference of subcutaneous tissue around the nasolabial fold
fold along with the buccal fat sags. Over time, the nasolabial fat superior to the fold becomes more hypertrophic, while the paranasal area inferior the fold and lateral to the ala nasi atrophies. These age-related changes further deepen the fold, and the difference in depths between the fold and surrounding skin becomes more pro­nounced (Fig.5.69).
The third type is not caused by differences in volume or sagging due to aging. Instead, the nasolabial fold is formed due to upper lip elevator muscles, levator labii superioris alaeque nasi, levator labii superioris, and zygomaticus minor
egion
yer
Tight subcutaneous lay on the upper lip region
and major muscles. These muscles insert to the skin where the nasolabial fold forms, lateral to the nose before nally inserting to the upper lip and the orbicularis oris muscle (Fig.5.70).
Insertions of the upper lip elevator muscles form a boundary that prevents the supercial fat from descending further. Muscle movement dur­ing smiling pulls on musculocutaneous area, causing the area inferior to the fold to appear deeper and the line more noticeable.
Although classied into three types by cause, the cause of nasolabial folds is multifactorial and may be associated with 2–3 of the aforemen-
LL
LLS muscle
e
Orbicularis oris muscle
5.2 Midface
173
Orbicularis oculi muscle
SAN muscle
Fig. 5.70 Upper lip elevator muscles on the nasolabial fold
Zygomaticus minor muscle
Zygomaticus major muscl
Fig. 5.71 Relationship of facial muscles to other facial structures in the nasolabial fold region— musculocutaneous attachment
tioned factors. Unlike in other parts of the cheek, this area contains a musculocutaneous attach­ment area and facial muscles course supercially. In addition, as the structure of tissue layers is dif­ferent Fig.5.71 and the facial artery runs parallel to the nasolabial fold, caution is required when injecting this region (Fig.5.72).
Technique for the Nasolabial Crease
Cases presenting only a slight depression in the paranasal area will require correction of the mild
crease only. The linear region slightly medial to the crease is targeted, and a needle is used to inject the ller along the crease into the subcuta­neous layer above the orbicularis oris muscle using the retrograde linear threading and fanning techniques (Fig.5.73).
In over 50% of Koreans, the facial artery along the nasolabial fold and the region where it branches into the superior labial artery course supercially, exposed above the orbicularis oris
174
duple
old line
Facial artery on the antegonial notch
Injection la
1. nasolabial cr
2.
3.
Infraorbital trunk of
x type facial artery
Fig. 5.72 Position of the facial artery around the nasolabial fold
Fig. 5.73 Injection
layer and technique for the nasolabial crease
Injection into slightly medial side to the
Subdermal layer Superficial injection for the lines & to
even out the surface (Fern leaf or Duck walk technique)
yer & technique
ease
5 Filler Procedures Based ontheFacial Area
Facial artery on the nasolabial f
muscle. Vessel injury can be avoided by inserting the needle in the supercial subdermal layer. Uneven surfaces that form after the injection can be smoothened out by injecting a softer ller into the dermal and subdermal layers (Fig.5.74).
Technique for Nasolabial Fold and Paranasal Depression
In cases involving both a paranasal depression and a deep nasolabial fold, the ller is typically placed in two layers. In the supercial layer, a soft ller is injected along the crease into the supercial subcutaneous tissue and subdermal layer with the inferior portion of dermis. Lateral to the ala nasi, a deeper plane is targeted with a
rmer ller. Fat layer deep to the muscle or Ristow’s space, a loose space supercial to the periosteum, is targeted (Fig.5.75).
In the triangular paranasal depression located between the alar groove and the crease, a needle can be inserted perpendicularly to the skin in the center of the triangle. This is a relatively safe zone with no major vascular structures. However, it is important to aspirate to ensure there has been no vessel injury before injecting (Fig.5.76).
The injection layer is adjusted according to the severity of the depression. With moderate depression, the ideal injection plane is the deep fat compartment deep to the muscles. Severe
Injection into two layers for the deep nasolabial f
1.
int the subder
2.
the paranasal deep f or Rist
base & the nasolabial fold mound
5.2 Midface
Fig. 5.74 Before and after treatment of the nasolabial crease
olds
Top layer
: Soft consistent filler injection
o the superficial subcutaneous or
mal layer
Bottom layer (Paranasal space)
: Firm consistent filler injection into
at compartment
ow’s space
175
Fig. 5.75 Injection planes for the nasolabial folds
Injection techniques
Fig. 5.76 Injection techniques for the paranasal depression
1. Center of triangular spaces requiring volumization
2. Bolus with layering & fanning injection into the depressed paranasal space
3. Supercial injections for the lines & to even the surface of the alar
176
Ristow’s space of the
5 Filler Procedures Based ontheFacial Area
depressions require larger volumes of ller. However, injecting large amounts of ller into the subcutaneous fat layer encompassing the deep fat will not create projection but rather cause lateral expansion. In severe cases, it is bet­ter to inject into Ristow’s space (Fig.5.77).
To locate Ristow’s space, slightly withdraw the needle after contact with the bone of the canine fossa. A loose space can be felt above the preperitoneal fat overlying the periosteum. With experience, the loose space could be felt immedi­ately after penetrating the deep fat layer without actually having to touch the bone and withdraw­ing the needle.
After the needle has been positioned in the deep fat compartment or Ristow’s space, add vol-
Deep fat tissue
Fig. 5.77 Ristow’s space for the injection of paranasal depression
paranasal region
ume by using the towering and layering tech­niques. During the procedure, use the ngers of the non-injecting, non-dominant hand to apply pressure on the bulging tissue superior to the crease. This will ensure that the ller does not ascend to the area superior to the crease.
After the depression has been corrected, the skin surface may be uneven from the demarca­tions formed between the augmented and non­augmented areas of the triangular region in the paranasal region, the alar groove, and crease. A soft ller should be injected into the subdermal and dermal layers to smoothen the area (Fig.5.78).
The long oblique creases external to the trian­gular region extending inferolaterally can be treated using the aforementioned technique for nasolabial crease (Fig.5.73).
Technique Using a Cannula
Anatomically, over 70% of Koreans have facial artery that courses medially to the nasolabial fold. It has been reported that even in cases where the facial artery courses lateral to the fold, it runs within 5mm from the fold in more than half of the cases. Therefore, safe entry point that mini­mizes the risk of vascular injury for cannula treatment can be located with the following method. Draw a line from the alar base to the mouth corner and divide the line into thirds. At the inferior third of this line, make the entry point 5 mm lateral to the crease. Move the cannula within the subcutaneous layer to reach the trian­gular region lateral to ala nasi. The injection layer and techniques are similar to that when using a
Fig. 5.78 Before and after treatment of the deep nasolabial folds with the paranasal depression
Injection entry point &
1. of nasolabial f alae
2. depr v
3. t
of the alar base & the nasolabial f mound
5.2 Midface
Fig. 5.79 Cannula injection for the nasolabial folds
177
techniques
Slightly lateral(5mm) to lower 1/3 point
old line from the nasal
to the mouth corner
Layering & fanning injection into the
essed paranasal space for the
olume augmentation
Retrograde linear threading & fanning
echnique for the superficial injections
for the lines & to even out the surface
needle to augment the paranasal area. The layer­ing and fanning techniques are used (Fig.5.79).
After augmenting the paranasal area, the can­nula can be withdrawn along the crease, and the retrograde linear threading and fanning tech­niques could be used to inject the ller into the supercial subcutaneous layer to smoothen the crease. Subsequently, if it is necessary to smoothen out the uneven surface of the injected area, a needle can be used to inject a very soft ller into the subdermal and dermal layers of the sunken region.
Nasolabial creases that become prominent when smiling can be treated botulinum toxin. Weakening the upper lip elevator muscles where
old
they insert to the skin will reduce the severity of the crease.
Nasolabial fat superior to the nasolabial crease does not atrophy with age. In fact, it is a fat layer that hypertrophies over time. The difference in soft tissue volume between the region inferior to the fold and the bulging of the nasolabial fat superior to the fold becomes marked over time, further deepening the crease. This difference in volume can be addressed by treating the fat layer with a lipolytic agent. Moreover, synergistic effects can be obtained when ller is combined with threads. Thread will elevate sagging tissue superior to the nasolabial crease and smoothen the skin surface, thus maximizing the effects of the injected ller (Fig.5.80).